Abnormal uterine bleeding and uterine pathology in patients on ...
2024年11月6日 · Tamoxifen is associated with an increased risk of uterine pathology. Benign endometrial polyps are the most common type of pathology. Other types of uterine pathology …
Tamoxifen and Uterine Cancer - ACOG
Women taking tamoxifen should be informed about the risks of endometrial proliferation, endometrial hyperplasia, endometrial cancer, and uterine sarcomas. They should be …
Gynecological side effects of tamoxifen - Food For Breast Cancer
2025年2月20日 · Women who experience postmenopausal bleeding during or after stopping tamoxifen should seek medical evaluation and surveillance. Tamoxifen can cause heavy …
Investigation of Women with Postmenopausal Uterine Bleeding: Clinical ...
Postmenopausal uterine bleeding, either spontaneous or that related to ovarian hormone replacement therapy (HRT) or selective estrogen receptor modulator (SERM) use (eg, …
Factors associated with endometrial pathology during tamoxifen …
Parity, endometrial thickness, and the presence of abnormal vaginal bleeding, but not age, body mass index, and menopausal status, may be associated with endometrial pathology during …
Abnormal uterine bleeding and uterine pathology in patients ... - UpToDate
2022年1月24日 · Tamoxifen is associated with increased risks of uterine pathology, including endometrial polyps, endometrial carcinoma and hyperplasia, uterine sarcoma, and uterine …
Recurrent breast carcinoma presenting as postmenopausal vaginal ...
We discuss the recurrence of breast carcinoma presenting as postmenopausal vaginal bleeding in a patient on Tamoxifen therapy. Case report illustrates widespread genital tract manifestation …
Committee Opinion No. 601: Tamoxifen and uterine cancer
Women taking tamoxifen should be informed about the risks of endometrial proliferation, endometrial hyperplasia, endometrial cancer, and uterine sarcomas, and any abnormal vaginal …
Tamoxifen associated uterine pathology in breast cancer
These data support the hypothesis that tamoxifen exerts a proliferative estrogen-like effect on the uterus. Abnormal bleeding in women under TAM treatment warrants prompt investigation and …
Abnormal uterine bleeding as a presenting sign of metastases to …
1999年3月1日 · We describe a breast cancer patient on tamoxifen therapy who presented with postmenopausal bleeding because of uterine metastases and review the pertinent literature.
- 某些结果已被删除